Testing the Feasibility, User Experiences, and Preliminary Effect of For Behavior Change and Collaborative Goal Setting in Primary Care: A Pilot Randomized Controlled Trial.

Our team developed (CCAs), a tool to help adolescents and health care providers (HCPs) communicate and collaboratively set behavior change goals. The objectives of this pilot randomized controlled trial were to test the feasibility, user experience, and preliminary effect of using CCAs with adolescents in primary care, focusing on behavior change and collaborative goal setting among adolescents. From March 2019 to September 2022, adolescents were recruited from the Northeast Community Health Centre (Edmonton, AB).

Feasibility, user experiences, and preliminary effect of on collaborative goal-setting and behavior change: protocol for a pilot randomized controlled trial.

Background: Adolescents and providers can benefit from practical tools targeting lifestyle modification for obesity prevention and management. We created (CCAs), a patient-centered communication and behavior change tool for adolescents and providers to use in clinical practice. The purpose of our study is to (i) assess the feasibility of CCAs in a real-world, practice setting to inform full-scale trial procedures, (ii) assess user experiences of CCAs, and (iii) determine the preliminary effect of CCAs on changing behavioral and affective-cognitive outcomes among adolescents.

Qualitative Analysis of the Most Cited Publications from Leading Indian Medical Institutions.

Background And Objectives: The most important responsibility of physicians is research - advancement of medical knowledge is the core on which the other responsibilities, patient care and research, are based. This study was planned to conduct a qualitative analysis of the major publications from the the country's leading medical institutions.

Methods: We used Scopus to generate a list of total number of publications from the topmost institutions, the number of citations, and citations per article.

Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence.

Introduction: Dual antiplatelet treatment is recommended by current clinical practice guidelines for patients undergoing PCI. The PLATO trial showed superiority of ticagrelor to clopidogrel in reducing the rate of death from vascular causes, myocardial infarction and stroke without increase in the rate of overall major bleeding in ACS patients. However, real world evidence in Indian patients is limited.